NFKB1 and Alzheimer disease: NF-κB pathway activation is reported to be required for the initiation of apoptosis, and also be a key mediator of neuroinflammation in various neurodegeneration disease including Alzheimer’s Disease and Parkinson’s Disease [53, 54].